Percutaneous PFO closure with amplatzer PFO occluder: Predictors of residual shunts at 6 months follow-up

Congenital Heart Disease

Volumn 4, Issue 4, 2009, Pages 252-257

  Greutmann, Matthias ^a,e   Greutmann Yantiri, Mehtap ^a   Kretschmar, Oliver ^b   Senn, Oliver ^b   Roffi, Marco ^c   Jenni, Rolf ^b   Luescher, Thomas F ^b   Eberli, Franz R ^d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Amplatzer PFO occluder; Cryptogenic stroke; Device closure; PFO; Residual shunt

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL SEPTAL ANEURYSM; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLIP; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE ASSOCIATION; EMBOLISM; FEMALE; FOLLOW UP; HEART ANEURYSM; HEART SEPTUM DEFECT; HEART SURGERY; HUMAN; MALE; PERCUTANEOUS PATENT FORAMEN OVALE CLOSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REPEAT PROCEDURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALSALVA MANEUVER;

ADULT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HEART ANEURYSM; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME;

EID: 68249150759     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2009.00302.x     Document Type: Article

References (17)

1. Herrmann HC, Silvestry FE, Glaser R, et al. Percutaneous patent foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center. Catheter Cardiovasc Interv. 2005;64:197-203.
2. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750-758.
3. Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol. 2005;45:377-380.
4. Harrer JU, Wessels T, Franke A, Lucas S, Berlit P, Klötzsch C. Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neurol Sci. 2006;33:39-47.
5. Wahl A, Kunz M, Moschovitis A, et al. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2008;94:336-341.
6. Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: Report of 80 consecutive cases. J Am Coll Cardiol. 1985;6:1370-1382.
7. Varma C, Benson LN, Warr MR, et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheter Cardiovasc Interv. 2004;62:519-525.
8. Khositseth A, Cabalka AK, Sweeney JP, et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc. 2004;79:35-41.
9. Bruch L, Parsi A, Grad MO, et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism: single-center experience. Circulation. 2002;105:2845-2848.
10. Giardini A, Donti A, Formigari R, et al. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia. Am J Cardiol. 2004;94:1012-1016.
11. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: Mid-term results of transcatheter closure in 256 patients. J Interv Cardiol. 2003;16:43-50.
12. Chatterjee T, Petzsch M, Ince H, et al. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol. 2005;18:173-179.
13. Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM; Amplatzer PFO Investigators. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv. 2003;60:524-528.
14. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J. 2004;25:424-430.
15. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart. 2004;90:186-190.
16. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation. 2000;101:893-898.
17. Zajarias A, Thanigaraj S, Lasala J, Perez J. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale. J Invasive Cardiol. 2006;18:533-537.